Page 545 - The Case Lab Book
P. 545

- Effective barriers to entry


                 Opportunities                                 Threats
                 - global markets                              - Ethics policy or lack of one
                 - developed country approval
                 - global expansion




               Withdraw Proxydychromil



                 Strengths                                      Weaknesses
                 - Well established company                     - No ethics policy
                 - international (local) coverage
                 - Financial strength


                 Opportunities                                  Threats
                 - Market needs this drug                       - Financial meltdown
                 - national/international
                 coverage
   540   541   542   543   544   545   546   547   548   549   550